Provider review

Willow tirzepatide review

Willow tirzepatide: dated cost records, plan details and questions to ask before enrolling. Public-source editorial, without a test purchase or clinical rating.

Illustration of bottles and boxes lined up on a shelf

Updated 2026-09-18 · Public-source editorial · See dated evidence below


Willow keeps it simple: one published price of $399 a month for compounded tirzepatide, with no membership and no tiers to decode.

Simplicity has value in a market this cluttered, and Willow’s single rate means there is no arithmetic to do. The trouble is that $399 is roughly double what the flat-rate leaders charge for the same class of medication.

Recorded costs and what to confirm

Comparison stepTirzepatide at Willow
Earlier figuresDated cost record
TreatmentName the product, route, prescribed amount and supply period
First paymentItemize medicine, care, tests, supplies and delivery
RenewalGive the next charge, its date and the supply it covers
Change or exitExplain remaining charges and any refund before payment

One published rate, no membership layer.

A year at $399 a month is roughly $4,788. The absence of a membership fee is welcome but does not close a gap that large.

How Willow works

Compounded GLP-1 provider with a single published monthly rate.

There is less published detail here than at larger competitors about how dose changes are handled, how quickly you can reach a clinician, or which pharmacy fills the prescription. Those are reasonable questions to ask before committing, and the answers are not on the website.

The earlier source record

  • Compounded tirzepatide listed at $399/month.

The underlying record is dated 2026-09-18. Its amounts, plan details and service descriptions are historical. Confirm the exact product, billing interval, included services and renewal terms before using a figure as a budget.

Where it is strong

  • A single price with no membership arithmetic.

Where it falls short

  • At $399/month it is priced well above the flat-rate leaders.
  • Thinner published detail about clinical support than larger competitors.

The thing most people miss

There is little published detail on how dose changes are handled. Ask before committing.

How it scored

The historical rubric gives Willow 2.9 out of 5. Display position 22 of 23 also reflects commercial placements; it is not a clinical quality rank. These scores have not been independently revalidated. See how we rate.

What we weighWeightScore
True monthly cost30%2.4 / 5
Price honesty20%3 / 5
Clinical support20%3.1 / 5
Pharmacy sourcing15%3.1 / 5
Cancelling15%3 / 5

Who it suits

Someone who wants one number and no decisions, and for whom the price difference is not decisive.

Our verdict

Clear pricing, high pricing, thin detail. Ask about dose changes and pharmacy sourcing before you sign up.

How it compares on tirzepatide

The full reasoning behind this order is in our best tirzepatide providers guide.

Read next

  • Coreage Rx tirzepatide review

    Coreage Rx tirzepatide: dated cost records, plan details and questions to ask before enrolling. Public-source editorial, without a test purchase or clinical rating.

  • Likeness Rx semaglutide review

    Likeness Rx semaglutide: dated cost records, plan details and questions to ask before enrolling. Public-source editorial, without a test purchase or clinical rating.

  • Trimi tirzepatide review

    Trimi tirzepatide: dated cost records, plan details and questions to ask before enrolling. Public-source editorial, without a test purchase or clinical rating.

  • The best tirzepatide providers in 2026

    23 historical provider records, with cost-component questions, clinical evidence limits and commercial placements explained.

  • Tirzepatide vs semaglutide

    One trial put them head to head. The result was not close — but the cheaper drug still wins for some people.

  • How to Compare GLP-1 Costs: Fees, Refills and Renewal

    Separate medication, care fees, supply duration, prepayment and renewal when comparing a GLP-1 quote.

Coreage Rx pays us a commission on sign-ups through our links. Commercial placements affect display order; the tables are not clinical recommendations. How we rate · Disclosure